Core Alternative Capital’s Chemours CC Stock Holding History

Core Alternative Capital’s Portfolio CC Stock Details CC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-40	Closed	-$634	–	234
2025 Q3	$634	Hold	40	–	–	﹤0.01%	308
2025 Q2	$458	Buy	+40	New	+$451	﹤0.01%	317

Other funds holding CC

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

CCPM

Cooper Creek Partners Management New York $4.21B AUM 44.81% 1-Year Est. Return

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Core Alternative Capital's CC Position: Q4 2025 in Review

Core Alternative Capital sold out of Chemours (CC) in Q4 2025, closing a stake of 40 shares — an estimated $634 sold.

Core Alternative Capital first reported a position in CC in Q2 2025 and held it in 2 quarters. The position peaked at $634 in Q3 2025. 435 funds tracked by Wall St. Rank hold CC as of Q4 2025.

Core Alternative Capital reported no remaining Chemours position as of Q4 2025 after selling out during the quarter.
Core Alternative Capital sold 40 Chemours shares in Q4 2025, an estimated $634.
Core Alternative Capital first reported a position in Chemours in Q2 2025 and held it in 2 quarters.
Core Alternative Capital's Chemours position peaked at $634 in Q3 2025.
435 funds tracked by Wall St. Rank held Chemours as of Q4 2025.

Based on Core Alternative Capital's 13F filing for Q4 2025, filed 2 Feb 2026.